Acute toxicity of postoperative IMRT and chemotherapy for endometrial cancer

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 25, Issue 9, 2007, Pages 439-445

  Tierney, Ryan M ^a   Powell, Matthew A ^a,b   Mutch, David G ^a,b   Gibb, Randall K ^a,b   Rader, Janet S ^a,b   Grigsby, Perry W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Washington University in St Louis School of Medicine   (United States)

Author keywords

Chemotherapy; Endometrial cancer; IMRT; Toxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; IFOSFAMIDE; PACLITAXEL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CANCER; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; RADIATION DOSE; UROGENITAL TRACT DISEASE; BRACHYTHERAPY; ENDOMETRIUM TUMOR; FEMALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARBOPLATIN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 39549094093     PISSN: 02882043     EISSN: 18625274     Source Type: Journal    
DOI: 10.1007/s11604-007-0163-1     Document Type: Article

References (28)

1. J Aalders V Abeler P Kolstad M Onsrud 1980 Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients Obstet Gynecol 56 4 419 27
2. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2005;106(2):413-25
3. CL Creutzberg WL van Putten PC Koper ML Lybeert JJ Jobsen CC Warlam-Rodenhuis 2000 Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial; PORTEC Study Group-Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 9213 1404 11
4. HM Keys JA Roberts VL Brunetto RJ Zaino NM Spirtos JD Bloss 2004 A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 3 744 51
5. KM Greven M Randall J Fanning M Bahktar P Duray A Peters 1990 Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium Int J Radiat Oncol Biol Phys 19 3 529 34
6. PW Grigsby CA Perez HM Camel M-S Kao AE Galakatos 1985 Stage II carcinoma of the endometrium: results of therapy and prognostic factors Int J Radiat Onc Biol Phys 11 1915 23
7. PW Grigsby C Perez RR Kuske M Kao A Galakatos 1987 Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium Gynecol Oncol 27 44 57
8. NA Mayr BC Wen JA Benda JI Sorosky CS Davis RW Fuller 1995 Postoperative radiation therapy in clinical stage I endometrial cancer: corpus, cervical, and lower uterine segment involvement-patterns of failure Radiology 196 2 323 8
9. ME Randall VL Filiaci H Muss NM Spirtos RS Mannel J Fowler 2006 Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study J Clin Oncol 24 1 36 44
10. CP Morrow BN Bundy HD Homesley WT Creasman NB Hornback R Kurman 1990 Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group study Gynecol Oncol 36 2 166 71
11. ME O'Brien M Killackey 1994 Adjuvant therapy in "high risk" endometrial adenocarcinoma (abstract) Proc ASCO 13 249
12. K Greven K Winter K Underhill J Fontenesci J Cooper T Burke 2004 Preliminary analysis of RTOG 9708: adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer Int J Radiat Oncol Biol Phys 59 1 16 73
13. Intensity-modulated radiotherapy: current status and issues of interest. Int J Radiat Oncol Biol Phys 2001;51(4):880-914
14. S Beriwal SK Jain DE Heron H Kim K Gerszten RP Edwards 2006 Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy Gynecol Oncol 102 2 195 9
15. CJ Brixey JC Roeske AE Lujan SD Yamada J Rotmensch AJ Mundt 2002 Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 54 5 1388 96
16. AE Lujan AJ Mundt SD Yamada J Rotmensch JC Roeske 2003 Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy Int J Radiat Oncol Biol Phys 57 2 516 21
17. AJ Mundt AE Lujan J Rotmensch SE Waggoner SD Yamada G Fleming 2002 Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies Int J Radiat Oncol Biol Phys 52 5 1330 7
18. FIGO 1989 International Federation of Gynecology and Obstetrics: classification and staging of malignant tumors in the female pelvis-annual report on the results of treatment in gynecological cancer Int J Gynaecol Obstet 28 189
19. A Taylor AG Rockall RH Reznek ME Powell 2005 Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 63 5 1604 12
20. DE Heron K Gerszten RN Selvaraj GC King D Sonnik H Gallion 2003 Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms small star, filled Gynecol Oncol 91 1 39 45
21. JC Roeske A Lujan J Rotmensch SE Waggoner D Yamada AJ Mundt 2000 Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies Int J Radiat Oncol Biol Phys 48 5 1613 21
22. CL Creutzberg WL van Putten PC Koper ML Lybeert JJ Jobsen CC Warlam-Rodenhuis 2001 The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial Int J Radiat Oncol Biol Phys 51 5 1246 55
23. FE Yang F Vaida L Ignacio A Houghton J Nauityal H Halpern 1995 Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy Int J Radiat Oncol Biol Phys 33 3 617 17
24. B Zachariah SS Jacob C Gwede A Cantor J Patil L Casey 2001 Effect of fractionated regional external beam radiotherapy on peripheral blood cell count Int J Radiat Oncol Biol Phys 50 2 465 72
25. A Lissoni A Gabriele G Gorga S Tumolo F Landoni C Mangioni 1997 Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma Ann Oncol 8 10 969 72
26. P Mauch L Constine J Greenberger W Knospe J Sullivan JL Liesveld 1995 Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy Int J Radiat Oncol Biol Phys 31 5 1319 39
27. PG Rose JA Blessing GS Lewandowski WT Creasman KD Webster 1996 A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study Gynecol Oncol 63 1 101 4
28. MM Turbow SC Ballon BI Sikic MM Koretz 1985 Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma Cancer Treat Rep 69 5 465 7